Aesculap Launches New Version of Cervical Fusion Device

Center Valley, Pa.-based Aesculap Implant Systems LLC has introduced the Cespace-XP interbody system for anterior cervical discectomy and fusion (ACDF) procedures. The system fuses Plasmapore-XP, an osteoconductive porous titanium coating, and a PEEK (polyetheretherketone)-Optima radiolucent core. Together, they are meant to deliver enhanced implant stability, artifact-free imaging, and an optimal scaffold for cervical fusion procedures. A comprehensive range of instrument and implant options are available to accommodate varying patient anatomies and intraoperative needs.

According to Aesculap, the Cespace-XP enhances stability and increases migration resistance through the roughened surface area provided by the Plasmapore-XP coating. The Cespace-XP includes a range of instrumentation and 30 size options to ensure the best possible fit to patient anatomy and intraoperative flexibility. The Plasmapore-XP coating is designed to clearly delineate implant contours during imaging, with X-ray marker pins for intraoperative positioning and verification.

“The Plasmapore-XP coating found on the Cespace-XP implant provides the ideal surface composition and architecture for direct bone contact, resulting in higher mechanical strength and improved implant stability,” said Bob Spiro, Ph.D., vice president of Aesculap Biologics and an expert in immunology and tissue regeneration.

The Cespace-XP is an interbody fusion device designed for use with autogenous bone graft and intended for spinal fusion procedures at one level in the cervical spine from sections C3-C7. The device gained 510(k) clearance from the U.S. Food and Drug Administration in April, predicated on the previous version of the same device.